首頁 › 乳癌 › 加州 › Santa Monica
Santa Monica, CA 的 乳癌 臨床試驗
28 項針對 乳癌 的研究正在 Santa Monica（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
招募中3 期
- Beverly Hills Cancer Center, Beverly Hills · 距離 6 英里
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- Precision NextGen Oncology & Research Center, Beverly Hills · 距離 6 英里
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
招募中2 期
- Beverly Hills Cancer Center, Beverly Hills · 距離 6 英里
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
招募中1 期
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
招募中
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
招募中1 期
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 距離 6 英里
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
招募中3 期
- Clinical Trial Site, Beverly Hills · 距離 6 英里
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
招募中2 期
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
招募中1/2 期
- Beverly Hills Cancer Center, Beverly Hills · 距離 6 英里
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
招募中3 期
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 距離 6 英里
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
招募中1/2 期
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
招募中2 期
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- 還有 1 項
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Tower Cancer Research Foundation, Beverly Hills · 距離 6 英里
- Cedars-Sinai Cancer - Tarzana, Tarzana · 距離 11 英里
- Kaiser Permanente-Woodland Hills, Woodland Hills · 距離 12 英里
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
招募中1 期
- Precision Next Gen Oncology & Research Center, Beverly Hills · 距離 6 英里
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
招募中2 期
- CS Cancer at Valley Oncology Medical Group, Tarzana · 距離 11 英里
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
招募中3 期
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
招募中3 期
- Kaiser Permanente-Woodland Hills, Woodland Hills · 距離 12 英里
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 距離 4 英里
- Precision NextGen Oncology & Research Center, Beverly Hills · 距離 6 英里
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
招募中1/2 期
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
招募中1 期
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Cedars-Sinai Cancer - Tarzana, Tarzana · 距離 11 英里
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
招募中觀察性研究
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Santa Monica 的其他研究
- 非小細胞肺癌45 項研究
- 大腸直腸癌23 項研究
- 癌症（所有類型）22 項研究
- 轉移性癌症19 項研究
- 肺癌15 項研究
- 卵巢癌15 項研究
- 前列腺癌15 項研究
- 頭頸部鱗狀細胞癌13 項研究
- 心臟衰竭11 項研究
- 子宮內膜癌10 項研究
- 胃癌9 項研究
- 胰臟癌9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。